Article Sidebar

Submitted
July 12, 2024
Published
June 30, 2024
Download
pdf
Statistic
Read Counter : 199 Download : 325

Main Article Content

Abstract

Dengue fever is a disease caused by the dengue virus (DENV) which often becomes a problem for public health in the world with approximately 390 million cases of infection. The lack of specific antiviral therapy for DENV is a driving force for the development of a dengue vaccine as a strategy to fight the DENV virus. This review discusses the development of dengue vaccines and makes effectivity comparisons with dengue vaccines that have been developed such as Dengvaxia, TV003/TV005, and DENVax to know the current status of the development of these vaccines.


Keywords : Dengue fever, Dengue Virus, vaccines, development, effectivity

Article Details

License

Copyright (c) 2024 Tisa Aulia

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
LITERATURE REVIEW: KAJIAN EFEKTIVITAS PERKEMBANGAN VAKSIN VIRUS DENGUE MASA KINI. (2024). Jurnal Kedokteran Raflesia, 10(1), 46–52. https://doi.org/10.33369/juke.v10i1.35777
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

    Abbas, A. K., Lichtman, A. H., & Pillai, S. (2012). Cellular and Molecular Immunology (7th ed.). Elsevier
    Saunders.
    Akter, R., Tasneem, F., Das, S., Soma, M. A., Georgakopoulos-Soares, I., Juthi, R. T., & Sazed, S. A.
    (2024). Approaches of dengue control: vaccine strategies and future aspects. In Frontiers in
    Immunology (Vol. 15). Frontiers Media SA. https://doi.org/10.3389/fimmu.2024.1362780
    Foucambert, P., Esbrand, F. D., Zafar, S., Panthangi, V., Cyril Kurupp, A. R., Raju, A., Luthra, G.,
    Shahbaz, M., Almatooq, H., & Khan, S. (2022). Efficacy of Dengue Vaccines in the Prevention of
    Severe Dengue in Children: A Systematic Review. Cureus, 14(9), e28916.
    https://doi.org/10.7759/cureus.28916
    Harapan, H., Michie, A., Sasmono, R. T., & Imrie, A. (2020). Dengue: A Minireview. Viruses, 12(8).
    https://doi.org/10.3390/v12080829
    Khetarpal, N., & Khanna, I. (2016). Dengue Fever: Causes, Complications, and Vaccine Strategies.
    Journal of Immunology Research, 2016, 1–14. https://doi.org/10.1155/2016/6803098
    Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V, Corver, J., Lenches, E., Jones, C. T.,
    Mukhopadhyay, S., Chipman, P. R., Strauss, E. G., Baker, T. S., & Strauss, J. H. (2002). Structure
    of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell, 108(5), 717–
    725. https://doi.org/10.1016/s0092-8674(02)00660-8
    Laydon, D. J., Dorigatti, I., Hinsley, W. R., Nedjati-Gilani, G., Coudeville, L., & Ferguson, N. M. (2021).
    Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of
    individual-level phase III data. ELife, 10. https://doi.org/10.7554/eLife.65131
    Ma, E., & Cheng, G. (2022). Host immunity and vaccine development against Dengue virus. Infectious
    Medicine, 1(1), 50–58. https://doi.org/10.1016/j.imj.2021.12.003
    Marimuthu, P., & Ravinder, J. R. (2016). Trends in clinical trials of dengue vaccine. Perspectives in
    Clinical Research, 7(4), 161–164. https://doi.org/10.4103/2229-3485.192035
    Murugesan, A., & Manoharan, M. (2020). Dengue Virus. In Emerging and Reemerging Viral Pathogens
    (pp. 281–359). Elsevier. https://doi.org/10.1016/B978-0-12-819400-3.00016-8
    Nanaware, N., Banerjee, A., Mullick Bagchi, S., Bagchi, P., & Mukherjee, A. (2021). Dengue Virus
    Infection: A Tale of Viral Exploitations and Host Responses. Viruses, 13(10).
    https://doi.org/10.3390/v13101967
    Nugraheni, E., Rizqoh, D., & Sundari, M. (2023). Manifestasi Klinis Demam Berdarah Dengue (DBD).
    Jurnal Kedokteran Dan Kesehatan : Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya,
    10(3), 267–274. https://doi.org/10.32539/jkk.v10i3.21425
    Thomas, S. J., & Yoon, I. K. (2019). A review of Dengvaxia®: development to deployment. Human
    Vaccines and Immunotherapeutics, 15(10), 2295–2314.
    https://doi.org/10.1080/21645515.2019.1658503
    Wilder-Smith, A. (2022). Dengue vaccine development: challenges and prospects. Current Opinion in
    Infectious Diseases, 35(5), 390–396. https://doi.org/10.1097/QCO.0000000000000871